ACORDA THERAPEUTICS INC 4
4 · ACORDA THERAPEUTICS INC · Filed Feb 13, 2017
Insider Transaction Report
Form 4
Blight Andrew
Chief Scientifc Officer
Transactions
- Exercise/Conversion
Common Stock
2017-02-09$22.13/sh+67,586$1,495,678→ 144,144 total - Sale
Common Stock
2017-02-09$22.41/sh−67,586$1,514,379→ 76,558 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-02-09−67,586→ 0 totalExercise: $22.13Exp: 2017-02-14→ Common Stock (67,586 underlying)
Footnotes (3)
- [F1]Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2017 on the expiration date reported within Table II unless exercised.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $22.25 to $23.05 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The shares subject to these options vested in installments and were fully vested on 1/01/2011.